Founded in 2017, Lacerta Therapeutics is a clinical-stage gene therapy company dedicated to discovering and developing AAV-based therapies. In 2020, Concept developed a new R&D Laboratory facility custom-built to Lacerta’s specifications located in Copeland Park in Alachua, Florida. The 12,950 square foot facility enables Lacerta to rapidly advance the development of their broad pipeline of AAV gene therapy product candidates in multiple therapeutic areas.